The original use of “Business As Usual” was during wartime, a deliberate attempt to maintain public calm while the world collapsed around them. So the question is this: What war, exactly, is the FSA trying to normalise? Against transparency, perhaps? If that is the case, it's interesting that it started at a time that is significant for CBD Novel Foods. That is provable through the 2021 FSA FOI report, which, other than a modified response on 17/06/21, shows an abrupt stop

This is bigger than novel foods. This is about regulatory manipulation and undeclared conflicts of a senior Civil Servant when investigating a complaint that was made in the public interest.

The 10mg ADI simply does not hold up, even for synthetic CBD, especially if a 300UF is likely excessive. Furthermore, the FSA’s exclusion of

There is every reason why the ACNFP should not be happy with RP427 The main issue is that the application itself is specifically for 10% CB

Regardless of the intent, is it right that the FSA stops, or targets companies for changing their labels to reflect consumer information tha

Have the Home Office dictated the direction of Novel Foods for CBD products? It's definitely a possibility, both in 2017 AND 2019!

please take time to answer the 20 short questions below. The results of this pole will be submitted to the FSA before 28/02/2023,